Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes
Ten reasons why DHBs need to act to control prescription pricing
+Columns
In print
OPINION
Ten reasons why DHBs need to act to control prescription pricing
Friday 9 February 2018, 04:19 PM

Anna Mickell
With Chemist Warehouse bursting onto the scene late last year offering zero prescription fees, prescription pricing has again become a topic of conversation. After working as a pharmacy wholesaler for 10 years, and in health in general for 35 years, pharmacy sector observer Anna Mickell has a few ideas on what works and what doesn’t. She gives her opinion on why prescription prices need to be controlled by DHBs
Despite a few left-leaning tendencies, I support a market approach when it comes to matters of health.
I think the Government and its agents need t
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.